BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 34635545)

  • 1. Celiac plexus neurolysis in pancreatic cancer: the endoscopic ultrasound approach.
    Seicean A
    World J Gastroenterol; 2014 Jan; 20(1):110-7. PubMed ID: 24415863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic ultrasound-guided celiac plexus neurolysis in pancreatic cancer-associated pain: different technical approaches in three challenging cases.
    Li Salvatierra B; Calixto-Aguilar L; Ruiz EF
    Rev Gastroenterol Peru; 2023; 43(4):368-372. PubMed ID: 38228304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for a randomized controlled trial of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN) with vs without bupivacaine.
    Esmail E; Paquin SC; Sahai AV
    Trials; 2023 Sep; 24(1):576. PubMed ID: 37684697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic Ultrasound-Guided Pain Management.
    Tavangar A; Samarasena JB
    Gastrointest Endosc Clin N Am; 2024 Jan; 34(1):179-187. PubMed ID: 37973228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Celiac Plexus Neurolysis Versus Splanchnic Nerve Neurolysis in the Management of Abdominal Cancer Pain: A Meta-analysis of 359 Patients.
    Lu F; Li X; Song L; Ye L; Wang X; Wang R
    Pain Physician; 2024 Jan; 27(1):1-10. PubMed ID: 38285023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Endoscopic Ultrasound-guided Celiac Plexus Neurolysis for Abdominal Pain in Patients With Unresectable Pancreatic Cancer: Network Meta-analysis of Randomized Controlled Trials.
    Okita M; Otani K; Matsui S
    J Clin Gastroenterol; 2023 Nov-Dec 01; 57(10):1054-1062. PubMed ID: 36227001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus delayed computed tomography-guided celiac plexus neurolysis for palliative pain management in patients with advanced pancreatic cancer: a retrospective cohort study.
    Lu F; Wang X; Tian J; Li X
    Front Neurol; 2023; 14():1292758. PubMed ID: 38020651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiac Plexus Neurolysis Is Associated With Decreased Survival in Patients With Pancreatic Cancer: A Propensity Score Analysis.
    Zylberberg HM; Nagula S; Rustgi SD; Aronson A; Kessel E; Kumta NA; DiMaio CJ; Lucas AL
    Pancreas; 2022 Feb; 51(2):153-158. PubMed ID: 35404890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer.
    Xuan M; Li N; Wu C
    Clinics (Sao Paulo); 2024; 79():100348. PubMed ID: 38552386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid burden in patients with inoperable pancreatic adenocarcinoma and the development of a multivariable risk prediction model for opioid use: A retrospective cohort study.
    Koulouris A; Baio G; Clark A; Alexandre L
    Pancreatology; 2023 Nov; 23(7):818-828. PubMed ID: 37741797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct intraoperative versus percutaneous computed tomographyguided celiac plexus neurolysis in non-resectable pancreatic cancer: A randomized, controlled, non-inferiority study.
    Abdelbaser I; Shams T; El-Giedy AA; Elsedieq M; Ghanem MA
    Rev Esp Anestesiol Reanim (Engl Ed); 2021 Sep; ():. PubMed ID: 34565567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma.
    Ali SH; Jorgensen T; Prasad RK; Wallingford G
    J Palliat Med; 2024 Apr; 27(4):576-578. PubMed ID: 37695828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer.
    Okita M; Otani K; Gibo N; Matsui S
    Pain Pract; 2022 Sep; 22(7):652-661. PubMed ID: 35748531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided neurolysis in advanced pancreatic cancer: current status.
    Hickman K; Godfrey E; Ajithkumar T
    BMJ Support Palliat Care; 2022 Mar; 12(1):22-28. PubMed ID: 34635545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and meta-analysis.
    Lu F; Dong J; Tang Y; Huang H; Liu H; Song L; Zhang K
    Support Care Cancer; 2018 Feb; 26(2):353-359. PubMed ID: 28956176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of pain response after endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain caused by pancreatic malignancy.
    Han CQ; Tang XL; Zhang Q; Nie C; Liu J; Ding Z
    World J Gastroenterol; 2021 Jan; 27(1):69-79. PubMed ID: 33505151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous retrocrural versus ultrasound-guided coeliac plexus neurolysis for refractory pancreatic cancer pain.
    Motoyama Y; Sato H; Nomura Y; Obata N; Mizobuchi S
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e81-e83. PubMed ID: 32527787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac plexus neurolysis in the management of unresectable pancreatic cancer: when and how?
    Wyse JM; Chen YI; Sahai AV
    World J Gastroenterol; 2014 Mar; 20(9):2186-92. PubMed ID: 24605017
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.